Lesion
Introduction
The nucleus incertus (NI), better known for its status as the principal source of neuronal relaxin-3, is a brainstem nucleus located ventral and medial to the posterodorsal tegmental nucleus (PDTg) in the pontine periventricular grey (Burazin et al., 2002; Goto et al., 2001; Olucha-Bordonau et al., 2003) . The NI neurons were initially shown to express the inhibitory neurotransmitter, gamma-aminobutyric acidco-express the recently discovered neuropeptide, relaxin-3 (Ma et al., 2007) . This small and distinct group of neurons has sparked off renewed interest due to its high expression of the corticotropin releasing hormone receptor type 1 (CRF 1 ) (Bittencourt and Sawchenko, 2000; Potter et al., 1994) , which suggests a role of the NI in the stress response. Subsequent studies reported the presence of other receptors in the NI, e.g. 5-hydroxytryptamine (5-HT or serotonin) receptor subtype 1A (5-HT 1A ) (Miyamoto et al., 2008) , and relaxin/insulin-like family peptide receptor 3 (RXFP3) (Sutton et al., 2004) . Other neuropeptides expressed by nucleus incertus include neuromedin B (Chronwall et al., 1985; Wada et al., 1990) and cholecystokinin (Kubota et al., 1983; Olucha-Bordonau et al., 2003) . Of particular interest, expression of relaxin-3 is highly specific and most abundant in the NI and only a small number of neurons in other nearby regions such as the pontine raphe nucleus, periaqueductal grey and dorsal substantia nigra express relaxin-3 (Tanaka et al., 2005) . As such, the NI -serves as a key point of regulation for functioning of the relaxin-3 neural circuitry.
The NI possibly exerts its actions through numerous projections to several parts of the brain, including the prefrontal cortex, medial septum (MS), hippocampus, amygdala, hypothalamus and the raphe nuclei (Goto et al., 2001 ) -areas that are implicated in various psychiatric conditions. Relaxin-3 binds to the RXFP3, which belongs to the family of relaxin peptide receptors that was recently elevated from orphan receptor status (van der Westhuizen et al., 2008 ). The precise functions of the NI and relaxin-3 remain largely undetermined but intriguing reports have been published in the past decade demonstrating the alleged role of the NI/relaxin-3/RXFP3 system in feeding behaviour (McGowan et al., 2006; McGowan et al., 2005) , stress (Burazin et al., 2002; Smith et al., 2012) , anxiety (Watanabe et al., 2011) and cognition (Cervera-Ferri et al., 2011; Farooq et al., 2013; Ma et al., 2009) . Recent studies show c-Fos expression in the nucleus incertus occurs in response to acute antipsychotic treatments in rats and polymorphisms in human relaxin-3 and RXFP3 associated with metabolic disturbances in patients with schizophrenia treated with antipsychotic drugs (Munro et al., 2012) . Thus the study of the NI and relaxin-3 is an exciting new frontier in behavioural neuroscience.
A strategy to achieve potent and selective lesioning of target brain structures has been to utilise cell-surface protein binding peptides or antibodies conjugated with saporin, a monomeric ribosomal inactivating protein (Heckers et al., 1994; Li et al., 2008; Thorpe et al., 1985; Waite et al., 1994) . Selectivity is achieved because, as a ribosomal toxin, the saporin is only toxic when internalised by the corresponding receptor. The corticotropin releasing factor (CRF)-saporin conjugate toxin, used in the present study, is expected to selectively ablate CRF 1 expressing cells (Hummel et al., 2010; Maciejewski-Lenoir et al., 2000) . On the premise that relaxin-3 expressing neurons in the NI predominantly co-express CRF 1 receptors (Tanaka et al., 2005) , the present investigation attempted to establish a method for selective ablation of the NI using the CRF-saporin conjugate. 
Results
Out of the total of 76 rats that underwent the surgical procedure, 43 receiving CRF-saporin and 33 serving as various controls, no mortality attributable to the CRF-saporin lesion was observed. Two rats were euthanised under veterinary advice because of an unrelated infection and a case of malocclusion of the incisors. In one experiment, postsurgical weight gain was monitored daily over 14 days but there was no significant difference in weight gain between the sham-and NI-lesioned rats (n ¼8 per group, n.s.). and TPH2 mRNA expression changes between sham-(n ¼ 4) and NI-lesioned (n¼ 4) groups. CRF 1 , relaxin-3 and GAD65 mRNA expression decreased significantly after CRF-saporin targeted lesioning. TPH2 mRNA expression was not affected by the lesion. Data are expressed as mean7SEM. *po0.05,**po0.01, ***po0.001.
2.1.
172 ng of CRF-saporin brings about a loss in CRF 1 expressing cells
To determine an appropriate dose of CRF-saporin, 40 Â , 20 Â and 10 Â dilutions of the original stock solution of CRFsaporin were infused separately into the NI of rats. CRF 1 immunofluorescence staining results showed that infusion of 172 ng of CRF-saporin was sufficient to bring about a loss in CRF 1 expressing cells in the NI (Fig. 1A-D) . This dose is therefore used for the subsequent experiments. The specificity of the CRF RI/II antibody was assessed by preabsorption of the antibody with the CRF blocking peptide, which abolished CRF 1 staining in the NI of naïve rats ( Fig. 2A-B ).
2.2.
CRF-saporin selectively targets and ablates CRF 1 positive cells
RT-PCR analysis showed that the NI-lesioned rats had a significant reduction in the expression of CRF 1 receptors compared to the sham-lesioned group. As hypothesised, corresponding decreases in the expression of relaxin-3 and GAD65 were also observed in the NI-lesioned rats (Fig. 3A) . TPH2 expression was unaltered in both the sham and NI-lesioned group as seen in the densitometry analysis of the PCR bands (Fig. 3B) . In a separate group of animals, a realtime PCR analysis showed that the CRF1, relaxin-3 and GAD65 mRNA expression in NI-lesioned rats was 0.004-, 0.02-and 0.07 fold relative to the sham-lesioned controls while TPH2 mRNA levels remained almost the same in both sham-and NI-lesioned rats (Fig. 3C) .
The protein expression assessed by western blotting of CRF 1 , pro-relaxin-3, GAD65 and TPH2 was similar among the naïve, saline injected, true sham (surgery but no infusion) and sham-lesioned (blank saporin infusion) groups ( Fig. 4A and B). However, protein levels of CRF 1 receptor was considerably reduced in the NI-lesioned rats. There was also a consistent decrease in the levels of pro-relaxin-3 in the NIlesioned rats as compared to the sham-lesioned rats (Fig. 4A) . The same set of samples was also checked for GAD65 and TPH2 protein levels. A significant decrease in the expression of GAD65 was also observed in the NI-lesioned rats while TPH2 protein levels remained unchanged. Densitometry analysis of the western blot demonstrated a statistically significant reduction in CRF 1 (approximately 54%), pro-relaxin-3 (approximately 53%) and GAD65 (approximately 64%) protein expression (Fig. 4B) .
Further confirmation of the lesion through immunofluorescence labelling verified the loss of CRF 1 receptor positive cells in the NI of the NI-lesioned rats as compared to the sham-lesioned rats ( Fig. 5A and B) . Similarly, relaxin-3 expressing cells also decreased considerably in the NIlesioned rats (Fig. 5D) . Examination of the TPH2 expression revealed that TPH2 positive cells lined the midline of the NI and were unaffected by the lesioning procedure ( Fig. 5E and F). Positive CRF 1 staining of the nearby locus coeruleus (LC) in both sham-and NI-lesioned rats was also detected (Fig. 5G and H) . Immunostaining for the glial cell marker, glial fibrillary acidic protein (GFAP), showed up-regulation of glial cells in the NI of both sham-lesioned and NI-lesioned rats at 14 days after surgery (Fig. 6 ).
2.3.
CRF-saporin in the NI decreases levels of relaxin-3 in the medial septum
The levels of pro-relaxin-3 in the MS in naïve, saline, true sham, sham-and NI-lesioned rats were assessed by western blotting. A decrease in relaxin-3 levels was observed in the MS of NI-lesioned rats (Fig. 7A ). Densitometry analysis of the blots showed an approximately 90% decrease in pro-relaxin-3 levels (Fig. 7B ).
2.4.
NI-lesioned rats displayed increased freezing in cued fear conditioning
The NI-lesioned and sham-lesioned rats were tested in a cued fear conditioning paradigm. The rats were first exposed to tone-shock pairing and subsequently freezing behaviour in response to the tone was assessed 24 h later. To determine if the NI-lesioned rats had any locomotor deficits, the total distance travelled by the sham-and NI-lesioned rats were measured during the 15 min habituation phase. There was a slight but insignificant decrease in the distance covered by the NI-lesioned rats ( Fig. 8A ) possibly due to the increased periods of freezing observed during this phase (Fig. 8B ). No significant difference between the percentage of freezing between sham-and NI-lesioned rats was observed during the tone-shock training phase (Fig. 8C) , for 2 min before ( Fig. 8D ) and during the 30 s tone at the 24 h test phase (Fig. 8D) . However, NI-lesioned rats displayed significantly greater freezing behaviour than the sham-lesioned rats in the 5 min period following the tone during the test phase (Fig. 8D ).
Discussion
We describe a method to ablate the NI neurons. CRF-saporin, lesioning neither caused mortality nor alteration in feed and water consumption, which is in agreement with the findings on relaxin-3 knockout mice (Smith et al., 2012; Smith et al., 2009; Watanabe et al., 2011) . Our results show that infusion of 172 ng of CRF-saporin was sufficient to bring about a significant loss in CRF 1 expressing cells in the NI. This was in accordance to the findings by Pascual's group where 1-2 mg of CRF-saporin injected ICV resulted in a significant loss in CRF 1 positive cells in the fundus of the striatum (FS) and lateral septum (LS) (Pascual and Heinrich, 2007) , suggesting that CRF-saporin was able to target and permanently silence CRF 1 expressing cells in the brain. Unconjugated saporin did not affect expression of CRF 1 as seen in the sham-lesion rat group, which was in agreement with the notion that the saporin protein alone does not bind to any receptors and cannot be taken in by the cells (Stirpe et al., 1983; Maciejewski-Lenoir et al., 2000) . Previous evidence has shown that all relaxin-3 expressing cells in the NI co-express CRF 1 and can be activated by ICV administration of CRF (Tanaka et al., 2005; Banerjee et al., 2010) , thus this study investigated the expression of relaxin-3 in the NI cells after the CRF-saporin targeted lesion. The consistent decrease in relaxin-3 expression corresponded to the findings that the NI cells express both CRF 1 and relaxin-3.
Together with the resultant decrease in relaxin-3 levels in one of the known projection targets of the NI, the MS, these data indicated that this lesion model is a possible tool for the study of relaxin-3 circuitry in the brain. Our lesion model also demonstrated a compelling decrease in GAD65 expression, a known indicator of GABAergic neurons. Relaxin-3 neurons in the NI were known to co-express GAD65 (Ma et al., 2007) , an important indication that the neurotransmission from the NI is inhibitory. Thus the resulting loss in GAD65 expression reinforced the findings that NI neurons are GABAergic and also provides an additional verification that CRF-saporin lesions the NI neurons.
The present method did not completely lesion the NI but was sufficient to produce a clear behavioural deficit. It might be possible to produce lesions of the NI to a greater extent by injecting greater volumes or concentrations of CRF-saporin. However, CRF 1 receptors are also present in other nearby structures such as the LC and there is a risk that the selectivity of the lesion will be compromised. Moreover, the NI spans only around 700 μm in the anterior-posterior aspect and hence multiple injections can cause physical injury to the cells, which is undesired. The NI and pontine raphe nucleus are both found caudal to the 5HT-neurons of the dorsal raphe nucleus. It was previously reported that distributions of 5HT-positive neurons and relaxin 3-expressing neurons intermingled but did not overlap (Tanaka et al., 2005) . In our lesion model, expression of TPH2 was unaffected by CRF-saporin infusions and TPH2 cells lining the midline of the NI were intact even at 14 days after the procedure. This finding reiterates the specificity of CRF-saporin in targeting only the cells that express the CRF 1 receptor. A recent paper reported that electrolytic lesion of the nucleus incertus retards extinction of auditory conditioned fear (Pereira et al., 2013) . However, electrolytic lesions lack cellular selectivity and may damage fibres of passage. Here we demonstrated that CRF-saporin selectively targets and ablates CRF 1 positive cells while leaving cells without the receptor unharmed, indicating the specificity. Moreover, earlier reports showed that CRFsaporin had a greater binding affinity to CRF 1 as compared to CRF 2α receptors (Maciejewski-Lenoir et al., 2000) , rationalising the use of CRF-saporin to selectively lesion the NI. Moreover, while the NI strongly expresses CRF 1 in the rat (Potter et al., 1994; Bittencourt and Sawchenko, 2000; Van Pett et al., 2000) there is no expression of CRF 2 (Van Pett et al., 2000) .
Although, the NI has been predicted to be involved in a variety of psychiatrically relevant conditions and manifestations, including stress, anxiety, depression, feeding behaviour, arousal and cognition (Ryan et (Ma et al., 2007; Sutton et al., 2004) and anatomical tract tracing of the afferent and efferent connexions of the NI (Goto et al., 2001; Hoover and Vertes, 2007; Olucha-Bordonau et al., 2003) . Current methods of studying the functions of the NI include electrical stimulation (Farooq et al., 2013; Nunez et al., 2006) , pharmacological activation with CRF (Farooq et al., 2013; Tanaka et al., 2005) and electrolytic lesioning (Pereira et al., 2013) of the NI to determine its putative modulatory role on mnemonic processing and behaviour. As the NI consists mostly of relaxin-3 positive neurons, numerous studies also use H3, relaxin-3, relaxin-3 agonist/antagonist, relaxin-3 knockout mouse models and silencing relaxin-3 in NI neurons to study the various postulated functions of the NI (Callander et al., 2012; Ma et al., 2009; Smith et al., 2012; Smith et al., 2009; Watanabe et al., 2011) . The present method to perturb the NI/relaxin-3 system using CRF-saporin is expected to open an additional approach for research to understand relevance of the NI/relaxin-3 system in behavioural neuroscience.
4.
Experimental procedure
Animals and surgery
Male Sprague-Dawley rats (270-290 g) were procured from the Centre for Animal Resources (CARE), National University of Singapore, were maintained under standard housing conditions (2172 1C, 12 h light-dark cycle and ad libitum food and water). All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC), National University of Singapore, and were in accordance with the guidelines of the National Advisory Committee for Laboratory Animal Research (NACLAR), Singapore, and the Guide for the Care and Use of Laboratory Animals, National Research Council of the National Academies, USA. Rats were anaesthetised with an intraperitoneal injection of a ketamine (75 mg/kg) and xylazine (10 mg/kg) cocktail, placed in a stereotaxic frame and burr holes were drilled on the skull at the coordinate corresponding to the NI (AP: 9.7 mm and ML:0-0.1 mm) (Paxinos and Watson, 2007) calculated from the bregma. Bilateral injections of 0.2 ml/site made 7.5 mm ventral to the surface of the skull delivered 21.5 ng, 43 ng or 86 ng/site Fig. 6 -Representative photomicrographs of GFAP staining in the NI of (A) naïve (n ¼ 3), (B) sham-lesioned (n¼ 3) and (C) NIlesioned rats (n ¼ 3) 14 days after the lesion. There is up-regulation of GFAP in both sham-(B) and NI-lesioned rats (C). Scale bars are 100 μm. of CRF-saporin or blank saporin (Advanced targeting Systems, USA) over 5 min. The needle was left in place for 5 more minutes before withdrawal. The scalp was sutured and the rat was allowed a rehabilitation period of 14 days before any experiments were carried out. Saline rats (n=3) received bilateral injections of 0.2 ml of saline. True sham lesions were produced by inserting the needle containing CRF-saporin into the NI without infusion. Sham lesions were produced by injection of blank saporin (n¼ 6) while lesions of the NI (n¼ 7) were produced by injection of CRF-saporin. Subsequently, the brains were freshly harvested (for RT-PCR, real-time PCR or western blot) or harvested after transcardial perfusion (for immunofluorescence studies on free floating sections) to check for the extent of the lesion. To determine if the lesion of the NI had an effect on behaviour, a separate group of sham-lesioned (blank saporin) and NI-lesioned (CRF-saporin) rats were subjected to a fear conditioning paradigm.
Perfusion fixation and fresh tissue harvest
Rats were anaesthetised with an overdose of pentobarbital prior to transcardial perfusion with 0.9% saline, followed by ) and (E) show the mean percentage freezing of rats for two minutes before and during the 30 s tone of the test phase (24h after the training). The mean percentage freezing time following the tone during the test phase (F) showed that NI-lesioned rats exhibit a longer freezing time compared to sham-lesioned rats. All data are represented as mean7SEM, *po0.05, ***po0.001.
4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The brain was removed immediately and post-fixed overnight at 4 1C and then saturated with 30% sucrose in phosphatebuffered saline (PBS). Free floating sections (30 mm) were obtained with a vibratome (Leica Microsystems, Germany). For qPCR and western blot analysis, the brains were removed immediately following anaesthesia and 500 mm sections collected using a rat brain matrix (Roboz Surgical, USA). The position of the NI and MS were confirmed under light microscope, and then collected with a Harris Uni-Core TM 1 mm micro-punch (Ted Pella Inc, USA) for further analysis.
Preparation of mouse anti-relaxin-3 antibody
To prepare the mouse anti-relaxin-3 antibody, HK4-144-10 cells (Kizawa et al., 2003) were obtained from the International Patent Organism Depository (IPOD), National Institute of Advanced Industrial Science and Technology (AIST), Japan, and first cultured in an antibiotic free GIT medium (Wako Pure Chemicals Industries Ltd., Japan). The recovered hybridoma cells were then allowed to grow vigorously to a log phase. The viability of the cells (490%) was determined before harvesting and freezing for ascities production. Mice were first inoculated intraperitoneally with monoclonal antibody-producing hybridoma cells; thereafter, the ascites fluid was collected and purified (1st Base, Singapore, ProSci Incorporated, USA). Further purification with Protein A agarose (Thermo Scientific, USA) and elution with 0.1 M citrate buffer containing 0.05% sodium azide were carried out. The eluate was concentrated in a centrifugal filter unit (Millipore, USA), washed with sterile phosphate buffered saline (PBS) and stored as a 1 mg/ml stock containing 0.05% sodium azide and 0.1% glycerol.
Immunofluorescence histochemistry
Sections were immunostained with a primary antibody solution which contained goat anti-CRF RI/II antibody (SC1757, 1:1000, Santa Cruz, USA), mouse anti-relaxin-3 antibody (1:1000), rabbit anti-tryptophan hydroxylase 2 (TPH2) antibody (AB5572, 1:1000, Chemicon, USA) or rabbit anti-glial fibrillary acidic protein (GFAP) antibody (Z0334, 1:1000, Dako, Denmark). Stained sections were subsequently visualised with donkey anti-goat Alexa Fluor 555 (1:400), donkey anti-mouse Alexa Fluor 488 (1:400) or goat antirabbit Alexa Fluor 488 (1:400) secondary antibodies, after which slides were washed and mounted using Prolong Antifade with DAPI (Invitrogen, Singapore) and viewed with a fluorescence microscope. The CRF RI/II polyclonal antibody used here was raised against the C-terminus of human CRF 1 , which is conserved across rat and mouse CRF 1 . Its specificity has been demonstrated previously by Chen et al. (2000) in experiments in which pre-incubation with the antigenic peptide abolished CRF 1 signals in western blots and staining in mouse brain sections. In mouse heart sections known to express only CRF 2 , no staining was observed (Chen et al., 2000) . To evaluate the specificity of this antibody in the NI neurons, a 10 Â relative concentration of the CRF blocking peptide (C-20P, Santa Cruz, USA) was pre-incubated with a 1:1000 dilution of the antibody overnight at 4 1C. NI sections were then incubated in this solution overnight and then further processed for CRF RI/II staining.
Reverse transcriptase and real-time polymerase chain reaction
Total RNA was extracted from the tissue and purified according to the manufacturer's instructions for PureLink RNA mini kit (Invitrogen, Singapore). The amount of RNA was quantified with a NanoDrop UV-vis spectrophotometer (Thermo Scientific, USA). Approximately 1 mg of total RNA was reverse transcribed with oligo(dT) primers using ImProm-II TM Reverse
Transcription system (Promega, USA). The PCR reaction was performed using the following sets of primers: CRF1 forward primer 5'-ACC GAC CGT CTG CGC AAG TG-3', reverse primer 5'-AGC GGA GCG GAC CTC ACT GT-3' (453 bp expected band size); relaxin-3 forward primer 5'-CTG CTG CTG GCT TCC TGG GCT CTC CTC GGG GCT CT-3', reverse primer 5'-TCG CTG GCC AGG TGG TCT GTA TTG GCT TCT CCA TCA-3' (218 bp expected band size) (Chen et al., 2005) ; GAD65 forward primer 5'-GAA CAG CGA GAG CCT GGT-3', reverse primer 5'-CTC TTG AAG AAG CTC ATT GG-3' (362 bp expected band size); TPH2 forward primer 5'-TAA ATA CTG GGC CAG GAG AGG-3', reverse primer 5'-GAA GTG TCT TTG CCG CTT CTC-3' (132 bp expected band size); and β-actin forward primer 5'-ATC CTG AAA GAC CTC TAT GC-3', reverse primer 5'-AAC GCA GCT CAG TAA CAG TC-3' (287 bp expected band size). The PCR conditions were conducted at 94 1C for 5 min, 30 cycles of 94 1C for 30 s, 60-65 1C for 1 min, 72 1C for 1 min followed by 10 min at 72 1C. The PCR products were then separated in 1.5% agarose gel, stained with ethidium bromide, and then visualised under UV irradiation. Real-time RT-PCR amplification on a separate group of sham-(n¼ 4) and NI-lesioned (n¼ 4) was carried out using the ViiA 7 Real-time RT-PCR system (Applied Biosystems, USA) with SYBR green PCR master mix (Applied Biosystems, USA) with the following gene-specific primers: CRF 1 forward primer 5'-ACG ACA AAC AAT GGC TAC CG-3', reverse primer 5'-GCA GTG ACC CAGGTA GTT GA-3'; relaxin-3 forward primer 5'-CCC TAT GGG GTG AAG CTC TG-3', reverse primer 5'-CCA GGT GGT CTG TAT TGG CT-3'; GAD65 forward primer 5'-GGG GTG GAG GGT TAC TGA TG-3', reverse primer 5'-ACC CAT CAT CTT GTG GGG AT-3'; TPH2 forward primer 5'-GCC TTT GCA AGC AAG AAG GT-3', reverse primer 5'-CGC CTT GTC AGA AAG AGC AT-3'; and β-actin forward primer 5'-ATC CTG AAA GAC CTC TAT GC-3', reverse primer 5'-AAC GCA GCT CAG TAA CAG TC-3'. β-actin was used as an internal control. The PCR conditions were an initial incubation of 50 1C for 2 min and 95 1C for 10 min followed by 40 cycles of 95 1C for 15 s and 59 1C for 1 min.
Western blot
Fresh NI/MS tissue was dissected and lysed with a radioimmunoprecipitation assay (RIPA) buffer (150 mM sodium chloride, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM Tris, pH 8.0). Proteins were first quantified with a Pierce bicinchoninic acid assay (BCA) kit (Thermo Scientific, USA), separated on a 12% sodium dodecyl sulphate (SDS)-PAGE and then transferred onto a polyvinylidene fluoride (PVDF) membrane. The membrane was blocked with 1% skim milk and incubated with a goat anti-CRF RI/II (1:1000, Santa Cruz, USA), rabbit anti-GAD65 (AB5082, 1:1000, Millipore, USA), rabbit anti-TPH2 (1:1000, Chemicon, USA) and rabbit anti-actin (A2066, 1:10 000, Sigma-Aldrich, USA) or 5% Bovine Serum Albumin (BSA) solution and incubated with mouse anti-RLX3 (1:2500) overnight at 4 1C. The blot was then washed and incubated with a HRP-conjugated anti-goat (1:5000), anti-rabbit IgG (1:5000) or goat anti-mouse Alexa Fluor 488 (1:5000) for 1 h at room temperature with agitation. The proteins were then detected with a chemiluminescence kit. Protein expression levels were normalised to actin.
Fear conditioning
Sham-and NI-lesioned rats were subjected to a fear conditioning paradigm (King and Williams, 2009) 14 days after surgery. The rats were first acclimatised to the room for 2 h before the start of each session. Habituation to the fear conditioning chambers (TSE Systems Inc., USA) was carried out for 15 mins for 4 days before training. The training phase consisted of a 2 min pause, and 6 repeats of 30 s tone with a 0.8 mA shock presented in the last 2 s of the 30 s tone. During the test phase 24 h later, the tone was sounded for 30 s without the shock. The time spent in freezing was recorded for 5 min following the tone. Freezing was detected by an array of infrared light beam sensors mounted 14 mm apart to monitor the position and movement of the animal inside the chamber (TSE Systems Inc., USA). All recordings were done via the TSE Systems software. This programme uses an averaging procedure to define the centre of gravity of the rat. An instance of freezing was defined as the animal not moving for more than a threshold duration of 5 s. Percentage freezing was calculated as the cumulative duration of freezing as a percentage of total time.
Analysis and statistics
RT-PCR gel and western blot images were analysed with ImageJ. The density of each band was measured and normalised to its corresponding actin band (RT-PCR: n ¼4 each for sham and NI-lesioned; western blot: n ¼3 for naïve, n ¼3 for saline, n¼ 3 for true sham, n¼6 for sham-lesioned and n¼ 7 for NI-lesioned). The densitometry data was statistically analysed with unpaired t tests (GraphPad Prism, USA) comparing sham-lesioned and NI-lesioned groups for each protein. For the real-time PCR (n¼ 4 each for sham and NIlesioned), the amplified transcripts were quantified using the comparative CT method (Livak and Schmittgen, 2001) , with the formula for relative fold change¼2
-ΔΔCT
. The means were analysed with unpaired t tests (GraphPad Prism, USA). Freezing behaviour (threshold set at 3 s) of the sham-lesioned (10) and NI-lesioned (n¼ 8) rats was recorded in 30 s epochs for a total of 5 min. Total percentage freezing time was calculated and analysed with an unpaired t test (GraphPad Prism, USA). The data were expressed as mean7SEM.
